F. Müller

发表

Human TNF‐α in transgenic mice induces differential changes in redox status and glutathione‐regulating enzymes

H. Prydz, H. Glosli, K. Tronstad, 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Events Type 1 (HIV-1) Infection: Correlation to Disease Progression and Clinical Elevated Levels of Serum-Soluble CD14 in Human Immunodeficiency Virus

S. Frøland, F. Müller, P. Aukrust, 2013 .

Elevated levels of serum-soluble CD14 in human immunodeficiency virus type 1 (HIV-1) infection: correlation to disease progression and clinical events.

S. Frøland, F. Müller, P. Aukrust, 1998, Blood.

The role of the tumor necrosis factor system and interleukin-10 during cytomegalovirus infection in renal transplant recipients.

H. Rollag, S. Frøland, F. Müller, 2000, The Journal of infectious diseases.

Levels of circulating adhesion molecules in congestive heart failure and after heart transplantation.

S. Frøland, T. Ueland, F. Müller, 1998, The American journal of cardiology.

Low numbers of regulatory T cells in common variable immunodeficiency: association with chronic inflammation in vivo

B. Fevang, S. Frøland, F. Müller, 2007, Clinical and experimental immunology.

Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients

Karl Erik Müller, F. Lund-Johansen, B. Fevang, 2020, Proceedings of the National Academy of Sciences.

Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19

Inge Christoffer Olsen, F. Lund-Johansen, J. Andersen, 2021, Annals of Internal Medicine.

Thiols to Treat AIDS

S. Frøland, F. Müller, P. Aukrust, 2000 .

Virological and immunological effects of antioxidant treatment in patients with HIV infection

R. Berge, S. Frøland, F. Müller, 2000, European journal of clinical investigation.

Activation of tumor necrosis factor — α system in HIV-1 infection: Association with markers of immune activation

N. Liabakk, S. Frøland, F. Müller, 2005, Infection.

IL‐10 in HIV infection: increasing serum IL‐10 levels with disease progression—down‐regulatory effect of potent anti‐retroviral therapy

S. Frøland, F. Müller, P. Aukrust, 1999, Clinical and experimental immunology.

Decreased bone formative and enhanced resorptive markers in human immunodeficiency virus infection: indication of normalization of the bone-remodeling process during highly active antiretroviral therapy.

J. Bollerslev, S. Frøland, T. Ueland, 1999, The Journal of clinical endocrinology and metabolism.

Possible role of interleukin-10 (IL-10) and CD40 ligand expression in the pathogenesis of hypergammaglobulinemia in human immunodeficiency virus infection: modulation of IL-10 and Ig production after intravenous Ig infusion.

S. Frøland, F. Müller, P. Aukrust, 1998, Blood.

Different effect of 1,25-dihydroxyvitamin D3 on replication of Mycobacterium avium in monocyte-derived macrophages from human immunodeficiency virus-infected subjects and healthy controls.

S. Frøland, F. Müller, P. Aukrust, 1998, Immunology letters.

Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency--possible immunologic and clinical consequences.

S. Frøland, F. Müller, P. Aukrust, 1996, Blood.

Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

S. Frøland, T. Ueland, F. Müller, 1999, The American journal of cardiology.

Titers of antibodies the receptor-binding domain (RBD) of ancestral SARS-CoV-2 are predictive for levels of neutralizing antibodies to multiple variants

F. Lund-Johansen, G. Nygaard, P. Magnus, 2022, bioRxiv.

Elevated plasma concentration of reduced homocysteine in patients with human immunodeficiency virus infection.

P. Ueland, R. Berge, S. Frøland, 1996, The American journal of clinical nutrition.

Increased levels of oxidized glutathione in CD4+ lymphocytes associated with disturbed intracellular redox balance in human immunodeficiency virus type 1 infection.

P. Ueland, R. Berge, S. Frøland, 1995, Blood.

Enhanced generation of reactive oxygen species in monocytes from patients with common variable immunodeficiency

F. Müller, S. FrØLand, P. Aukkust, 1994, Clinical and experimental immunology.

Impaired base excision repair and accumulation of oxidative base lesions in CD4+ T cells of HIV-infected patients.

E. Seeberg, M. Bjørås, S. Frøland, 2005, Blood.

Tetradecylselenoacetic Acid, a PPAR Ligand With Antioxidant, Antiinflammatory, and Hypolipidemic Properties

J. Nordrehaug, T. Ueland, F. Müller, 2007, Arteriosclerosis, thrombosis, and vascular biology.

Release of cytokines, soluble cytokine receptors, and interleukin-1 receptor antagonist after intravenous immunoglobulin administration in vivo.

N. Liabakk, S. Frøland, F. Müller, 1994, Blood.

Enhanced expression of inflammatory cytokines and activation markers in T-cells from patients with chronic heart failure.

S. Frøland, F. Müller, P. Aukrust, 2003, Cardiovascular research.

Increased serum osteoprotegerin in disorders characterized by persistent immune activation or glucocorticoid excess--possible role in bone homeostasis.

K. Godang, J. Bollerslev, S. Frøland, 2001, European journal of endocrinology.

Is there a link between cytomegalovirus infection and new-onset posttransplantation diabetes mellitus? Potential mechanisms of virus induced β-cell damage

H. Rollag, A. Hartmann, T. Jenssen, 2005 .

The leucocyte protein L1 (calprotectin): a putative nonspecific defence factor at epithelial surfaces.

M. Steinbakk, F. Müller, P. Brandtzaeg, 1995, Advances in experimental medicine and biology.

HIV-1 Env gp120 C2V5 Potential N-Linked Glycosylation Site(s) (PNGs) Variations and Amino Acid Length Polymorphisms among Infected Family Members

B. Stray-Pedersen, F. Müller, K. Kristiansen, 2011 .

The effect of 1,25‐vitamin D3 on maturation of monocytes from HIV‐infected patients varies with degree of immunodeficiency

H. Rollag, M. Degré, F. Müller, 1996, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Glutathione redox disturbances in human immunodeficiency virus infection: immunologic and therapeutic consequences.

F. Müller, P. Aukrust, 1999, Nutrition.

Immunomodulating effects of 3‐thia fatty acids in activated peripheral blood mononuclear cells

R. Berge, S. Frøland, T. Ueland, 2003, European journal of clinical investigation.

Altered IgG-subclass distribution in lymph node cells and serum of adults infected with human immunodeficiency virus (HIV).

S. Frøland, F. Müller, P. Brandtzaeg, 1989, Clinical and experimental immunology.

Nonspecific oral immunity in individuals with HIV infection.

H. Rollag, S. Frøland, M. Degré, 1992, Journal of acquired immune deficiency syndromes.

Persistent T‐cell exhaustion in relation to prolonged pulmonary pathology and death after severe COVID‐19: Results from two Norwegian cohort studies

B. Fevang, T. Ueland, F. Müller, 2022, Journal of internal medicine.

High Circulating Levels of the Homeostatic Chemokines CCL19 and CCL21 Predict Mortality and Disease Severity in COVID-19

B. Fevang, T. Ueland, F. Müller, 2022, The Journal of infectious diseases.

Abnormal interleukin-7 function in common variable immunodeficiency.

S. Frøland, F. Müller, P. Aukrust, 2005, Blood.

Decreased levels of total and reduced glutathione in CD4+ lymphocytes in common variable immunodeficiency are associated with activation of the tumor necrosis factor system: possible immunopathogenic role of oxidative stress.

R. Berge, S. Frøland, F. Müller, 1995, Blood.